AURKA and breast neoplasm: At the genomic level, five out of seven PDX carried amplification or CN gains of CCND1 gene with additional alterations in cell cycle genes CCNE2, CDK7, AURKA or CCNB1. For six patients, we could match the copy number profile of patient’s primary breast tumour and PDX (with the bone met.